Exchange: NASDAQ·Updated 05:43 AM EDT
PBLS logo

PBLS Parabilis Medicines Inc.

$23.10
$0.35
(1.54%)
Pre-Market
Prev Close $22.75
EarningsNov 12
Mkt Cap$2.81B
Vol27,984.00

About PBLS

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
35

Bearish Sentiment

How do you feel about PBLS?

Advertisement|Remove ads.